MONT-SAINT-GUIBERT, Belgium, December 03, 2021--(Company WIRE)--Regulatory News:Celyad Oncology SA (Euronext & Nasdaq:CYAD) ("Celyad" or the "Business"), a scientific-phase biotechnology business...
MONT-SAINT-GUIBERT, Belgium, December 03, 2021--(Company WIRE)--Regulatory News:Celyad Oncology SA (Euronext & Nasdaq:CYAD) ("Celyad" or the "Business"), a scientific-phase biotechnology business...